Similarly, an increase in TP53 and Rb1 mRNA expression was observed in both cell lines following treatment with EPZ6438 and ZLD1039, while cisplatin-treated cells displayed a decrease for both tumour suppressors (Figure 6C). This evidence concerns the gene TP53 and neoplasm.